Loading...
Febuxostat, a novel xanthine oxidoreductase inhibitor, improves hypertension and endothelial dysfunction in spontaneously hypertensive rats
Xanthine oxidase (XO) is an enzyme responsible for the production of uric acid. XO produces considerable amount of oxidative stress throughout the body. To date, however, its pathophysiologic role in hypertension and endothelial dysfunction still remains controversial. To explore the possible involv...
Saved in:
| Published in: | Naunyn Schmiedebergs Arch Pharmacol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Springer Berlin Heidelberg
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4939152/ https://ncbi.nlm.nih.gov/pubmed/27198514 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00210-016-1239-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|